Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea 2020-04-16 18:00
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA 2020-04-16 12:30
Three Chinese Vaccines against COVID-19 are on the Way 2020-04-16 11:03
Australia to test COVID-19 vaccine 2020-04-15 11:15
Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19 2020-04-15 05:55
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma 2020-04-14 21:15
Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen" 2020-04-13 22:25
Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic 2020-04-13 21:55
Seegene Receives Health Canada Approval for its COVID-19 Assay 2020-04-13 21:00
PharmaBlock Opens New Chemistry and Engineering Technology Center in Zhejiang 2020-04-13 20:00
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions 2020-04-13 20:00
AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility 2020-04-10 14:00
Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS 2020-04-09 20:00
World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight 2020-04-09 15:57
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis 2020-04-09 15:14
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries 2020-04-08 03:57
HOYA/PENTAX Medical Issues Statement Regarding U.S. Department of Justice Settlement 2020-04-07 23:36
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study 2020-04-07 20:00
CROMSOURCE Announces Launch of COVID-19 Clinical Trial 2020-04-07 19:01
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today 2020-04-06 20:30
1 299 300 301 302 303 412